Enhanced Lactobacillus Paracasei MG4272 Strain for Vaginal Health

This inventive concept presents a suite of direct improvements and enhancements to the original Lactobacillus paracasei MG4272 strain, offering better antimicrobial effects, increased acid resistance, and enhanced delivery methods for vaginal health applications.

The original patent disclosed a Lactobacillus paracasei MG4272 strain with antimicrobial activity against Gardnerella vaginalis and Candida albicans. However, the strain's limitations, such as pH sensitivity and lack of optimized delivery methods, hinder its effectiveness in real-world applications. This new inventive concept addresses these limitations by introducing novel methods for enhancing the strain's antimicrobial effects, improving its acid resistance, and developing targeted delivery systems.

The inventive concept encompasses five key aspects: 1) a method for fermenting the Lactobacillus paracasei MG4272 strain in a nutrient-rich medium to enhance its antimicrobial effects; 2) a composition combining the strain with a prebiotic to boost its antimicrobial activity; 3) a system for preventing vaginal infections using the strain and a delivery device; 4) a method for improving the acid resistance of the strain through gradual acidification and mutant selection; and 5) a diagnostic kit utilizing the strain and a detection reagent to identify vaginal infections. These innovations overcome the original patent's limitations, providing a more effective and efficient solution for vaginal health.

The new claims introduce novel and non-obvious improvements to the original patent, including the use of nutrient-rich media, prebiotics, and targeted delivery systems. These enhancements demonstrate a significant inventive step, as they overcome the original patent's limitations and provide a more effective solution for vaginal health applications.

Alternative embodiments of the inventive concept could include using different nutrient-rich media, exploring various prebiotic combinations, or developing alternative delivery devices, such as suppositories or creams. These variations ensure broad conceptual coverage and adaptability to diverse vaginal health applications.

The enhanced Lactobacillus paracasei MG4272 strain has significant commercial potential in the vaginal health market, with applications in prevention and treatment of vaginal infections, maintenance of vaginal flora, and diagnosis of vaginal disorders. The target industries include pharmaceuticals, nutraceuticals, and medical devices.